ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      85.365
      0.30%
      Bitcoin
      63,359.79
      1.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. KALA BIO Inc (KALA)

      7. KALA BIO Inc (KALA) News

      KALA

      KALA BIO (KALA)

      KALA BIO Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KALA
      DateTimeSourceHeadlineSymbolCompany
      09/10/20208:00AMBusiness WireKala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™NASDAQ:KALAKALA BIO Inc
      09/08/20208:00AMBusiness WireKala Pharmaceuticals to Present at Upcoming Investor Conferences in SeptemberNASDAQ:KALAKALA BIO Inc
      08/06/20205:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KALAKALA BIO Inc
      08/06/20207:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      08/06/20207:00AMBusiness WireKala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      08/04/20208:00AMBusiness WireKala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual ConferenceNASDAQ:KALAKALA BIO Inc
      07/30/20204:01PMBusiness WireKala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference CallNASDAQ:KALAKALA BIO Inc
      07/17/20204:01PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      06/30/20209:23AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      06/30/20209:22AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      06/30/20209:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      06/30/20209:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      06/26/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      06/25/20204:06PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KALAKALA BIO Inc
      06/22/20204:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      06/11/20204:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      06/10/20208:11AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KALAKALA BIO Inc
      06/10/20208:00AMBusiness WireKala Pharmaceuticals Announces Virtual-Only Format for 2020 Annual Meeting of StockholdersNASDAQ:KALAKALA BIO Inc
      05/27/20208:00AMBusiness WireKala Pharmaceuticals to Present at Jefferies Virtual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
      05/26/20208:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      05/26/20208:00AMBusiness WireKala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye DiseaseNASDAQ:KALAKALA BIO Inc
      05/20/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KALAKALA BIO Inc
      05/07/20205:24PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:KALAKALA BIO Inc
      05/07/20204:13PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KALAKALA BIO Inc
      05/07/20207:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      05/07/20207:00AMBusiness WireKala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      05/06/20208:00AMBusiness WireKala Pharmaceuticals to Present at BofA Securities 2020 Health Care ConferenceNASDAQ:KALAKALA BIO Inc
      05/04/20208:00AMBusiness WireKala Pharmaceuticals Resubmits New Drug Application for EYSUVIS™ for Dry Eye DiseaseNASDAQ:KALAKALA BIO Inc
      05/01/202011:13AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:KALAKALA BIO Inc
      04/30/20208:00AMBusiness WireKala Pharmaceuticals to Report First Quarter 2020 Financial Results and Host Conference CallNASDAQ:KALAKALA BIO Inc
       Showing the most relevant articles for your search:NASDAQ:KALA